Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07528027) titled 'Phase III Study of HRS-7535 for Hypertension With Overweight or Obesity' on April 7.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: Shandong Suncadia Medicine Co., Ltd.

Condition: Hypertension With Overweight or Obesity

Intervention: Drug: HRS-7535

Recruitment Status: Not recruiting

Phase: Phase 3

Date of First Enrollment: May 2026

Target Sample Size: 648

Countries of Recruitment: China

To know more, visit https://cli...